Pay in 4 interest-free payments of $6.44 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Convenient, though systemic exposure is lower than injectable
Melanotan II activates MC1R, MC3R, MC4R and MC5R
On April 1, 2026, the FDA approved orforglipron (Foundayo) by Eli Lilly for adults with obesity or overweight who also have weight-related medical problems to reduce excess body weight and maintain weight reduction long term, alongside a reduced-calorie diet and increased physical activity
Final treatment options and eligibility should be reviewed by your provider during your appointment.
US$ 22.48
US$ 22.98
US$ 27.75
US$ 20.82
US$ 22.33
US$ 20.69
US$ 25.30
US$ 25.08
US$ 28.76
US$ 27.49
US$ 29.76
